5月11日,在北京举行的2019北京国际摩托车展览会上,光阳摩托(KYMCO)举行了盛大的新品发布会,3款电摩陆续登场,可谓新品璀璨,熠熠生辉。这3款电摩分别是:电动重机超跑SuperNEX概念车,以及搭载'正弦波内转子'电机的专业级电动踏...5月11日,在北京举行的2019北京国际摩托车展览会上,光阳摩托(KYMCO)举行了盛大的新品发布会,3款电摩陆续登场,可谓新品璀璨,熠熠生辉。这3款电摩分别是:电动重机超跑SuperNEX概念车,以及搭载'正弦波内转子'电机的专业级电动踏板摩托i-Like EV系列的i-Like EV pro版和i-Like EV标准版。3款车的发布,标志着光阳于去年宣布进军新能源市场后,已进入首发旗舰机种即将上市的实质性发展阶段。展开更多
AIM:To assess the validity of the Milan and University of California San Francisco(UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation(OLT) in patients with hepatocellular carcinoma(HC...AIM:To assess the validity of the Milan and University of California San Francisco(UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation(OLT) in patients with hepatocellular carcinoma(HCC) in a single-center study.METHODS:This study is a retrospective review of prospectively collected data.Between 1998 and 2009,56 of 356 OLTs were performed in patients with HCC.Based on pathological examination of liver explants,patients were retrospectively categorized into 3 groups:Milan +(n = 34),Milan-/UCSF +(n = 7) and UCSF-(n = 14).RESULTS:Median follow-up period was 39.5(1-124) mo.The 5-year overall survival rates in the Milan +,Milan-/UCSF + and UCSF-groups were 87.7%,53.6% and 33.3%,respectively(P < 0.000).Within these groups,tumor recurrence was determined in 5.8%,14.3% and 40% of patients,respectively(P < 0.011).Additionally,the presence of microvascular invasion within the explanted liver had a negative effect on the 5-year disease free survival(74.7% vs 46.7%,P < 0.044).CONCLUSION:The Milan criteria are reliable in the selection of suitable candidates for OLT for the treatment of HCC.For cases of OLT involving living donors,the UCSF criteria may be applied.展开更多
文摘5月11日,在北京举行的2019北京国际摩托车展览会上,光阳摩托(KYMCO)举行了盛大的新品发布会,3款电摩陆续登场,可谓新品璀璨,熠熠生辉。这3款电摩分别是:电动重机超跑SuperNEX概念车,以及搭载'正弦波内转子'电机的专业级电动踏板摩托i-Like EV系列的i-Like EV pro版和i-Like EV标准版。3款车的发布,标志着光阳于去年宣布进军新能源市场后,已进入首发旗舰机种即将上市的实质性发展阶段。
文摘AIM:To assess the validity of the Milan and University of California San Francisco(UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation(OLT) in patients with hepatocellular carcinoma(HCC) in a single-center study.METHODS:This study is a retrospective review of prospectively collected data.Between 1998 and 2009,56 of 356 OLTs were performed in patients with HCC.Based on pathological examination of liver explants,patients were retrospectively categorized into 3 groups:Milan +(n = 34),Milan-/UCSF +(n = 7) and UCSF-(n = 14).RESULTS:Median follow-up period was 39.5(1-124) mo.The 5-year overall survival rates in the Milan +,Milan-/UCSF + and UCSF-groups were 87.7%,53.6% and 33.3%,respectively(P < 0.000).Within these groups,tumor recurrence was determined in 5.8%,14.3% and 40% of patients,respectively(P < 0.011).Additionally,the presence of microvascular invasion within the explanted liver had a negative effect on the 5-year disease free survival(74.7% vs 46.7%,P < 0.044).CONCLUSION:The Milan criteria are reliable in the selection of suitable candidates for OLT for the treatment of HCC.For cases of OLT involving living donors,the UCSF criteria may be applied.
